Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia

Scott H. Kaufmann, Judith E. Karp, Mark R. Litzow, Ruben Anthony Mesa, William Hogan, David P. Steensma, Karen S. Flatten, David A. Loegering, Paula A. Schneider, Kevin L. Peterson, Matthew J. Maurer, B. Douglas Smith, Jacqueline Greer, Yuhong Chen, Joel M. Reid, S. Percy Ivy, Matthew M. Ames, Alex A. Adjei, Charles Erlichman, Larry M. Karnitz

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences